XOMA Ltd.
XOMA - 5 More Stocks
on Wall Street's Dollar Menu - Sourced - WhisperFromWallStreet.com
WhisperfromWallStreet.com is a FREE award winning newsletter
that specializes in sending alerts to our subscribers on stocks we think are
going to run, why we think so, as well as teaching you how to become a better
trader. We scan hundreds of stocks a day to find those that meet our criteria
and when we find one, we send you an alert. We have sent out 40 alerts so far
in 2009 with an average price gain of over 80%. Please join risk free and see
for yourself.
Sign up for our FREE alerts at WhisperfromWallStreet.com
---
XOMA Ltd. XOMA
0.79 Down 0.03 (3.66%) 6:15PM ET
It's now been nine months since I wrote the original "5 Stocks on Wall
Street's Dollar Menu" article. I was surprised at the time to find so many
recognized stocks trading for less than $1 a share. Even more household names
would join the list in the months to come, as familiar companies in all
industries buckled under the market's malaise.
ABOUT
XOMA Ltd., a biopharmaceutical company, engages in the discovery, development,
and manufacture of therapeutic antibodies and other agents to treat
inflammatory, autoimmune, infectious, and oncological diseases. The company
receives royalties on three approved products: RAPTIVA, which is marketed
globally for the treatment of chronic moderate-to-severe plaque psoriasis;
LUCENTIS, which is marketed globally for the treatment of neovascular (wet)
age-related macular degeneration; and CIMZIA, which is approved in the
Last Trade: 0.82
Day's Range: 0.7860 - 0.84
52wk Range: 0.37 - 2.40
Volume: 1,502,369
<<<
---
Here are a few alerts our WhisperfromWallStreet.com
subscribers enjoyed.
SPNG 1000%
AMNG 241%
RKBD 300%
UTRM 169%
TLLE 266%
Sign up to receive free stock alerts
---
Disclaimer: Full disclaimer at http://whisperfromwallstreet.com/disclaimer.php
WhisperfromWallStreet.com (WFWS) based upon information believed
to be reliable herein prepared all material. The information contained herein
is not guaranteed by WFWS to be accurate, and should not be considered to be
all-inclusive. The companies that are discussed in this opinion have not
approved the statements made in this opinion. This opinion contains
forward-looking statements that involve risks and uncertainties. This material
is for informational purposes only and should not be construed as an offer or
solicitation of an offer to buy or sell securities. WFWS is not a licensed
broker, broker dealer, market maker, investment banker, investment advisor,
analyst or underwriter. Please consult a broker before purchasing or selling
any securities viewed on http://www.whisperfromwallstreet.com or mentioned
herein. WFWS may have been compensated with shares or with cash from third
party shareholders or the company on behalf of one or more of the companies
mentioned in this opinion.
This release contains "forward-looking statements" within the meaning
of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities
Exchange Act of 1934, as amended and such forward-looking statements are made
pursuant to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. "Forward-looking statements" describe future
expectations, plans, results, or strategies and are generally preceded by words
such as "may", "future", "plan" or
"planned", "will" or "should",
"expected," "anticipates", "draft", "eventually"
or "projected". You are cautioned that such statements are subject to
a multitude of risks and uncertainties that could cause future circumstances,
events, or results to differ materially from those projected in the
forward-looking statements, including the risks that actual results may differ
materially from those projected in the forward-looking statements as a result
of various factors, and other risks identified in a companies' annual report on
Form 10-K or 10-KSB and other filings made by such company with the Securities
and Exchange Commission. You should consider these factors in evaluating the
forward-looking statements included herein, and not place undue reliance on
such statements. The forward-looking statements in this release are made as of
the date hereof and WFWS undertakes no obligation to update such statements.
This is not a solicitation to buy or sell any securities.
WhisperfromWallStreet.com, nor any of its affiliates are not registered
investment advisors or a broker dealers. Never invest in any stock featured on
our site or emails unless you can afford to lose your entire investment.
CONTACT: WhisperFromWallStreet.com
